| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas
|
Duggan, Megan C.
|
|
2016
|
65 |
11 |
p. 1353-1364
|
artikel
|
| 2 |
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas
|
Duggan, Megan C.
|
|
|
65 |
11 |
p. 1353-1364
|
artikel
|
| 3 |
Beta-glucan contamination of pharmaceutical products: How much should we accept?
|
Barton, Claire
|
|
2016
|
65 |
11 |
p. 1289-1301
|
artikel
|
| 4 |
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015
|
Maio, Michele
|
|
2016
|
65 |
11 |
p. 1423-1431
|
artikel
|
| 5 |
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
|
Fenstermaker, Robert A.
|
|
2016
|
65 |
11 |
p. 1339-1352
|
artikel
|
| 6 |
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial
|
Ascierto, Paolo A.
|
|
2016
|
65 |
11 |
p. 1395-1400
|
artikel
|
| 7 |
Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells
|
Richards, John O.
|
|
2016
|
65 |
11 |
p. 1337
|
artikel
|
| 8 |
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma
|
Tiper, Irina V.
|
|
2016
|
65 |
11 |
p. 1411-1421
|
artikel
|
| 9 |
Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes
|
Gloger, Andreas
|
|
2016
|
65 |
11 |
p. 1377-1393
|
artikel
|
| 10 |
NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells
|
Richards, John O.
|
|
2016
|
65 |
11 |
p. 1325-1335
|
artikel
|
| 11 |
Quantification of PD-L1 and PD-1 expression on tumor and immune cells in non-small cell lung cancer (NSCLC) using non-enzymatic tissue dissociation and flow cytometry
|
Chargin, Amanda
|
|
2016
|
65 |
11 |
p. 1317-1323
|
artikel
|
| 12 |
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma
|
Miki, Kentaro
|
|
2016
|
65 |
11 |
p. 1401-1410
|
artikel
|
| 13 |
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice
|
Lanterna, Claudia
|
|
2016
|
65 |
11 |
p. 1303-1315
|
artikel
|
| 14 |
The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression
|
Acker, Aline Van
|
|
2016
|
65 |
11 |
p. 1365-1375
|
artikel
|
Tijdschrift beschrijving